Cronos (CRON) Asset Writedowns and Impairment (2019 - 2026)
Cronos' (CRON) quarterly Asset Writedowns and Impairment came in at $107000.0 in Q1 2026, up 1088.89% year-on-year from $9000.0 in Q1 2025, and down 84.71% quarter-over-quarter from $700000.0 in Q4 2025.
Cronos (CRON) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Cronos' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $107000.0 for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 1088.89% year-over-year to $107000.0 in Q1 2026; TTM through Mar 2026 was $6.3 million, a 73.24% decrease from a year earlier, with the FY2025 full-year figure at $700000.0, down 93.75% from the prior year.
- Asset Writedowns and Impairment retreated to $107000.0 in Q1 2026 per CRON's latest filing, from $700000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $29.0 million in Q3 2022 and bottomed at $9000.0 in Q1 2025.
- The 5-year median for Asset Writedowns and Impairment is $10.4 million (2024), against an average of $9.8 million.
- Across the five-year window, Asset Writedowns and Impairment jumped 20302.82% in 2022 and slumped 99.93% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $21.2 million in 2022, then increased by 10.24% to $23.3 million in 2023, then slumped by 98.52% to $345000.0 in 2024, then surged by 102.9% to $700000.0 in 2025, then slumped by 84.71% to $107000.0 in 2026.
- Per Business Quant, the three latest CRON Asset Writedowns and Impairment figures stand at $107000.0 (Q1 2026), $700000.0 (Q4 2025), and $3.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 3.03 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Sep 30, 2024 | 10.42 Mn |
| Sep 30, 2024 | 10.42 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Mar 31, 2024 | 12.73 Mn |
| Mar 31, 2024 | 12.73 Mn |
| Dec 31, 2023 | 23.35 Mn |
| Dec 31, 2023 | 23.35 Mn |